Impulsivity, cognitive inflexibility, and brain network dysregulation in etomidate use disorder: A clinical and EEG microstate study
Etomidate, a short-acting GABA_A receptor modulator and emerging novel psychoactive substance, is increasingly abused non-medically. Despite rising clinical concern, the neuropsychological profiles of etomidate use disorder (EUD) remain poorly characterized, prompting this systematic investigation of its clinical and neurophysiological features. 152 individuals with EUD and 67 age-matched healthy controls (HC) were recruited. Participants completed a series of standardized assessments measuring craving, impulsivity, inhibitory control, and habitual behavior.
Resting-state EEG data were analyzed using microstate analysis to characterize the temporal organization of large-scale brain activity, and a multidimensional feature-based support vector machine (SVM) model was built to distinguish EUD from HC. The EUD group exhibited significantly higher craving and impulsivity, and poorer performance on stop-signal and reversal learning tasks. Microstate analysis revealed significantly longer durations of microstates B, C, and D and reduced occurrence of microstate A in the EUD group.
SVM classification achieved an AUC of 0.777. This is the first comprehensive characterization of EUD, demonstrating distinct clinical features and alterations in the temporal organization of large-scale brain activity. These findings characterize cross-sectional clinical and neurophysiological features associated with EUD and highlight the potential value of EEG microstate analysis to probe such brain network temporal changes.
We would like to thank all the participants who contributed to this study. We are also grateful to the research staff and collaborators for their support during data collection and analysis. The authors are supported by the Science and Technology Innovation 2030 “Brain science and brain-like research” Major Project of China (2021ZD0202102) and National Key Research and Development Program of China (2023YFC3304200).
Department of Psychiatry, National Center for Mental Disorders, National Clinical Research Center for Mental Disorders, the Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, People’s Republic of China Zhenjiang Liao, Xinxin Chen, Juan Le, Xingmin Wang, Xuhao Wang, Ying Tang & Hongxian Shen Department of Psychology, School of Humanities and Management, Hunan University of Chinese Medicine, Changsha, Hunan, China Correspondence to Ying Tang or Hongxian Shen. The authors declare no competing interests. This study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving research study participants were approved by the ethics committee of the Second Xiangya Hospital, Central South University.
Written informed consent was obtained from all participants/patients. All authors consent to the publication of this manuscript. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extract — continue reading at the source.